FDA Inspection 1220078 — Jeffrey A. Levy, M.D.
The FDA completed an inspection of Jeffrey A. Levy, M.D. on September 29, 2023 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 29, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miami, FL (United States)
Additional Details
Clinical BA/BE